Evidence map›Paper›PMID 21862643›Full record

ArticleInvestigative ophthalmology & visual science2011

The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.

Sanja Pajovic, Timothy W Corson, Clarellen Spencer, Helen Dimaras, Marija Orlic-Milacic, Mellone N Marchong, Kwong-Him To, Brigitte Thériault, Mark Auspitz, Brenda L Gallie

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Heterogeneity in retinoblastoma: a tale of molecules and models.Clinical and translational medicine · 2017
    Review
  4. Article
  5. Article
  6. Article
  7. Retinoblastoma.Nature reviews. Disease primers · 2015
    Review
  8. Transgenic Models in Retinoblastoma Research.Ocular oncology and pathology · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Animal models in retinoblastoma research.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society · 2013
    Article
  13. The genomic landscape of retinoblastoma: a review.Clinical & experimental ophthalmology
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sanja PajovicDivision of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada.
Timothy W Corson
Clarellen Spencer
Helen Dimaras
Marija Orlic-Milacic
Mellone N Marchong
Kwong-Him To
Brigitte Thériault
Mark Auspitz
Brenda L Gallie
Ontario Institute for Cancer Research · CAPrincess Margaret Cancer Centre · CAIndiana University – Purdue University Indianapolis · US

Funding

Progression from Developing Retina to RetinoblastomaR01CA118830 · NCI · UNIVERSITY HEALTH NETWORK · PI GALLIE, BRENDA L · 2005 to 2009
$1.0M
NCI NIH HHS R01 CA118830NCI NIH HHS R01CA118830
6 · The paper itself

Abstract

purposeHuman retinoblastoma arises from an undefined developing retinal cell after inactivation of RB1. This is emulated in a murine retinoblastoma model by inactivation of pRB by retinal-specific expression of simian virus 40 large T-antigen (TAg-RB). Some mutational events after RB1 loss in humans are recapitulated at the expression level in TAg-RB, supporting preclinical evidence that this model is useful for comparative studies between mouse and human. Here, the characteristics of the TAg-RB cell of origin are defined.

methodsTAg-RB mice were killed at ages from embryonic day (E)18 to postnatal day (P)35. Tumors were analyzed by immunostaining, DNA copy number PCR, or real-time quantitative RT-PCR for TAg protein, retinal cell type markers, and retinoblastoma-relevant genes.

resultsTAg expression began at P8 in a row of inner nuclear layer cells that increased in number through P21 to P28, when clusters reminiscent of small tumors emerged from cells that escaped a wave of apoptosis. Early TAg-expressing cells coexpressed the developmental marker Chx10 and glial markers CRALBP, clusterin, and carbonic anhydrase II (Car2), but not TuJ1, an early neuronal marker. Emerging tumors retained expression of only Chx10 and carbonic anhydrase II. As with human retinoblastoma, TAg-RB tumors showed decreased Cdh11 DNA copy number and gain of Kif14 and Mycn. It was confirmed that TAg-RB tumors lose expression of tumor suppressor cadherin-11 and overexpress oncogenes Kif14, Dek, and E2f3.

conclusionsTAg-RB tumors displayed molecular similarity to human retinoblastoma and origin in a cell with features of differentiated Müller glia with progenitor properties.

Indexed as

AnimalsAntigens, Polyomavirus TransformingApoptosisBiomarkers, TumorCaspase 3Cell DifferentiationCell LineageCell ProliferationDNA, NeoplasmFluorescent Antibody Technique, IndirectGene Expression RegulationGene SilencingKi-67 AntigenMiceMice, Inbred C57BLNeoplastic Stem CellsAntigens, Polyomavirus Transformingbeta3 tubulin, mouseBiomarkers, TumorCasp3 protein, mouseCaspase 3DNA, NeoplasmKi-67 AntigenRetinoblastoma ProteinTubulin

Identifiers

PMID21862643
PMCPMC3183982
OpenAlexW1989654480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.